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Abstract
Background: Venous thromboembolism (VTE) including deep vein thrombosis (DVT) and pulmonary embolism 
(PE) is a leading cause of death in cancer patients. The aim of this study was to explore the potential risk factor of 
VTE in oral and maxillofacial oncological surgery.
Material and Methods: The data of patients who received operation in our institution were gathered in this ret-
rospective study. A diagnosis of VTE was screened and confirmed by computer tomography angiography (CTA) 
of pulmonary artery or ultrasonography examination of lower extremity. Medical history and all perioperative 
details were analyzed.
Results: 14 patients were diagnosed as VTE, including 6 cases of PE, 7 cases of DVT, 1case of DVT and PE. The 
mean age of these patients was 62.07 years. Reconstruction was performed in 12 patients of these cases, most of 
which were diagnosed as malignance. Mean length of surgery was 8.74 hours, and lower extremity deep venous 
cannula (DVC) was performed in all these patients.
Conclusions: We analyzed several characters of oral and maxillofacial surgery and suggested pay attention to 
lower extremity DVC which had a high correlation with DVT according to our data.
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Introduction
Thromboembolism is a well recognized complication of 
malignant disease and it is known that malignant disease 
itself can predispose to a hyper-coagulable state second-
ary to polycythemia vera. And cancer patients have a 
higher incidence of venous thromboembolism (VTE), 
including pulmonary embolism (PE) and deep venous 
thrombosis (DVT), compared to the general population 
(1). Therefore, cancer patients undergoing major surgery 
are considered particularly high risk for VTE.
The incidence of thromboembolic disease in general 
population is relatively low, about 0.1%-0.3% per year 
while among cancer patients, the occurrence of VTE is 
4–7 times higher, depending on the type and the stage 
of cancer (2). Several retrospective studies revealed 
the incidence of VTE in head and neck cancer patients 
between 0.1% and 2% (3-7). The largest review was 
published by Moreano (3) and reviewed the records of 
12,805 otolaryngologic patients with an overall inci-
dence of DVT and pulmonary embolism of 0.3% and 
0.2%, respectively. Patients with head and neck cancer 
usually undergo comprehensive resection and recon-
struction and frequently exhibit many of the major risk 
factors for DVT and PE. These risk factors include ad-
vanced age, postoperative immobility, prolonged surgi-
cal procedure and et al. In accord with current criteria, 
most patients with head and neck cancer who have sur-
gery are presumed to be high risk for developing VTE, 
especially for patients undergoing simultaneous recon-
struction. The purpose of this study was to identify 
potential risk factors of VTE in oral and maxillofacial 
oncological surgery.
Material and Methods
This study was approved by the Ethics Committee of 
Shanghai Ninth People’s Hospital. All the patients with 
tumor, including benign or malignant tumors, discharged 
from January 2011 to December 2015, that received op-
eration in Oral Maxillofacial-Head Neck Department, 
Shanghai 9th Hospital were selected for study. All the 
detail of medical history was recorded, including gen-
der, age, smoke/alcohol history, comorbidities, previous 
surgeries, prior chemotherapy or radiation therapy, prior 
VTE history, histology, preoperative D-dimer and et al. 
The characters of the surgery procedure were recorded 
including operative time, blood loss, blood transfusion, 
lower extremity DVC, simultaneous reconstruction and 
et al. Perioperative findings were summarized includ-
ing abnormal symptoms and the time point as discov-
ered, diagnosis method, treatment and other complica-
tions (Tables 1-3).
Finally, a total of 9724 patients were included in this 
study and 14 patients were diagnosed as VTE, including 
6 cases of PE, 7 cases of DVT, 1case of DVT and PE. 
The overall incidence of VTE was about 0.14%. The di-
agnoses were confirmed by computer tomography angi-
ography (CTA) of pulmonary artery or ultrasonography 
examination of lower extremity.
Patient VTE Gender Age Smoke Alcohol Comorbidities Medication Previous surgery 
Pathological 
Diagnosis D-dimer 
1 DVT M 48 + + - - +          SCC 0.4 
2 DVT M 73 - + 
Pituitary 
adenoma 
Hypopituitarism 
Prednisone, 
Levothyroxine 
Sodium, 
VitaminD 
+ 
(CR) 
SCC 
recurrence 
6.45/ 
4.31 
3 DVT F 58 - - Hypertension Indapamide, Amlodipine + SCC / 
4 DVT M 61 + + - - - SCC 0.58 
5 DVT F 53 - - - - - SCC / 
6 DVT M 50 - - - - + (CR) 
ACC 
recurrence / 
7 DVT M 72 - - - - - SCC / 
8 DVT PE F 32 - - - - - Ameloblastoma  
9 PE F 78 - - Cerebral infarction - 
+ 
(CR) 
SCC 
recurrence 0.64 
10 PE M 69 - - Diabetes - - MEC 0.58 
11 PE M 70 - - Diabetes Metformin, Diamicron - SCC / 
12 PE F 59 - - Hypertension - + ACC 0.29 
13 PE M 74 + + - - - SCC / 
14 PE M 72 - - - - - SCC / 
!
Table 1. Preoperative medical record detail.
Abbreviations: M, male; F, female; SCC, squamous cell carcinoma; MEC, mucoepidermoid carcinoma; ACC, adenoid cystic carcinoma; CR, 
cancer related.
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Patient VTE 
Operative program 
Surgery 
procedure 
hour  
Blood loss 
ml  
Blood 
transfusion
ml  Flap 
Reconstruction 
Vascular 
Anastomosis Tracheotomy 
1 DVT - - + 10.75 300 400 
2 DVT PMMF - + 8.5 800 1000 
3 DVT ALTFL + + 11.83 1000 1000 
4 DVT Forearm Flap + - 7 400 0 
5 DVT Forearm Flap + - 9.75 500 0 
6 DVT Fibula FlapR + + 10.75 1000 600 
7 DVT - - - 4.58 500 0 
8 DVT PE DCIAR + - 9 450 0 
9 PE PMMF - + 8 800 400 
10 PE ALTFR + + 10.25 700 400 
11 PE ALTFR + + 7.25 700 0 
12 PE ALTFL + + 9 650 0 
13 PE ALTFL + + 10 500 200 
14 PE - - - 5.5 300 0 
!
Patient VTE Postoperative prophylaxis 
Caprini 
Score 
Lower extremity 
DVCday  Initial symptoms 
Time point 
(post-op day) 
Postoperative 
complications Treatment 
1 DVT Alprostadil 10 3R Pain in lower extremity DVC (R) 13 PI 
Inferior vena cava 
filter Anti-infection 
therapy 
2 DVT - 11 4R Swelling of footR 10 PI Pleural effusion 
Immobilization  
LMWH  
Anti-infection therapy  
3 DVT Alprostadil 10 3R 
Swelling and increased 
 skin temperature of 
 lower extremityL 
9 PI 
Inferior vena cava 
filter  
Urokinase 
thrombolysis 
4 DVT Alprostadil 11 5R Pain in lower extremity DVCR 6 - 
Immobilization 
+LMWH 
5 DVT Alprostadil 10 0L Swelling of lower extremity (L) 0 - 
Immobilization 
+LMWH 
6 DVT Alprostadil 10 3L Swelling of lower extremity (R) 8 PI LMWH 
7 DVT - 9 1R Pain in lower extremity (R) 5 - 
Immobilization + 
LMWH 
8 DVT PE Alprostadil 9 3L 
Swelling of lower 
extremity (R) 3 - 
Urokinase 
thrombolysis  
Warfarin 
9 PE Alprostadil 12 3R Thoracalgia  Decline of SPO2 3 PI 
LMWH  
Anti-infection therapy 
10 PE - 11 /L Decline of SPO2 5 PI Atelectasis 
LMWH  
Anti-infection therapy 
11 PE - 11 3L Fever + Decrease of PaO2 9 PI Immobilization + LMWH 
12 PE - 10 3R Decline of SPO2 6 PI Pleural effusion LMWH 
13 PE - 11 6R Decline of SPO2 3 
PI 
Aspiration 
pneumonia 
LMWH 
14 PE - 11 5R 
Chest tightness 
Expiratory dyspnea  
Pain in groin 
12 PI 
Inferior vena cava 
filter  
 Urokinase 
thrombolysis 
!
Table 2. Medical record details of operation.
Abbreviations: PMMF, pectoralis major myocutaneous flap; ALTF, anterior lateral thigh flap; DCIA, deep circumflex iliac 
artery; L, left; R, right.
Table 3. Postoperative medical record details.
Abbreviations: LMWH, low molecular weight heparin; PI, pulmonary infection; post-op, post operation; L, left; R, right.
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Results
The mean age of these patients was 62.07 years (±12.95; 
range from 32 to 78). There were 9 men and 5 women. 
4 patients had a smoking history and 5 patients had a 
history of alcohol intake. In the term of basic disease, 
2 patients had a history of hypertension and 2 patients 
had got diabetes. 6 patients had suffered a previous sur-
gery including 3 malignance resulted in operation, and 
1 operation was lower extremity involved. One patient 
had received a prior chemotherapy and radiotherapy 
(Table 4). Reconstruction was performed in 12 patients 
of these cases, most of which were all diagnosed as ma-
lignance, including 1 fibula flap, 1 DCIA flap, 2 forearm 
flaps, 2 pectoris major myocutenous flaps (PMMF) and 
6 anterior lateral thigh flaps (ALTF) (Table 5).
Mean length of surgery was 8.74 hours (±2.06; range 
from 4.58 to 10.75). Mean blood loss was 628.57ml (± 
222.50; range from 1000 to 300), and 7 patients got blood 
transfusion and mean amount was 592.86ml(±322.01; 
Variable Patients with VTE
Mean Age ± SD（years） 62.07±12.95
Age group
＜45 1
≥45 13
Gender
                                            Male 9
                                          Female 5
Smoking 4
Alcohol 5
Basic disease
Hypertension 2
Diabetes 2
Previous surgery
 Yes 6
No 8
Malignant disease
     Yes 13
SCC 10
ACC 2
MEC 1
         No 1
Prior chemotherapy/radiotherapy
                                               Yes 1
                                               No 13
Preoperative D-dimer
＜0.5 2
≥0.5 4
Table 4. Patient characteristics.
Characteristics Outcome
Mean operation time±SD（hours） 8.74±2.06
Reconstruction surgery
Yes 12
                                   Fibula Flap 1
                           DCIA 1
                                  Forearm Flap 2
                                         PMMF 2
                                      ALTF 6
No 2
Mean blood loss （ml） 628.57±222.50
Blood transfusion
                          Yes 7
                          Mean amount（ml） 592.86±322.01
                          No 7
Lower extremity DVC
Yes 14
                                 Right side 9
                              Left side 5
Mean time±SD（days） 3.23±1.59
No 0
Intraoperative anticoagulation 0
Postoperative anticoagulation
Yes 7
                                       LMWH 0
                                  Alprostadil 7
No 7
Mechanical prophylaxis 0
Time point of presentation of VTE
  (Mean postoperative days) 6.57±3.76
Other complications
                          Pulmonary infection 9
                          Pleural effusion 2
                        Aspiration pneumonia 1
Table 5. Statistical perioperative findings.
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range from 200 to 1000) (Table 5). Lower extremity 
DVC was performed in all 14 patients via femoral vein 
puncture, 5 cases in left side and 9 cases in right side. 
Among the 8 patients of DVT, 5 cases occurred on the 
ipsilateral of DVC and initial symptom was the pain 
and swelling at the position of DVC. The other 3 cases 
occurred on the ipsilateral of flap and initial symptom 
was the pain and swelling of the lower extremity (Table 
3). The mean time of DVC usage was 3.23 days (±1.59; 
range from 0 to 6) (Table 5). DVC was usually removed 
within 5 days, and the rule was broken only in 1 patient 
whose DVC was removed in the 6th day. In particular, 
one patient was discovered swelling in the position of 
femoral vein puncture in the end of the surgery and a 
diagnosis of DVT was made. For this case, the time of 
DVC usage was recorded as 0 day (Table 3). 
Postoperative prophylaxis was recorded. Antico-
agulation was performed in 7 patients and alprostadil 
was used rather than LMWH (low molecular weight 
heparin) (Table 3). Mechanical prophylaxis, neither 
graduated elastic stocking (GES) nor intermittent pneu-
matic compression (IHC) was performed. The time 
point of presentation of VTE ranged from the end of the 
surgery to 13th day post operation, and the mean was 
6.57 days (±3.76) post operation (Table 5). Most of the 
initial symptom of DVT was pain and swelling of lower 
extremity whereas decline of oxygen saturation (SPO2) 
and pressure of arterial oxygen (PaO2) was the most 
common initial symptom of PE (Table 3). For the cases 
of PE, pulmonary artery trunk was embolized in one 
case (Fig. 1A), and inferior vena cava filter and uroki-
nase thrombolysis was performed. For the cases whose 
pulmonary arteriole was embolized (Fig. 1B), pulmo-
nary infection was always discovered; the decline of 
SPO2 was corrected when LMWH and anti-infection 
therapy were performed simultaneously. For the cases 
of DVT, immobilization and LMWH were required in 
every case; inferior vena cava filter was employed in 2 
cases in case of deadly PE (Table 3).
Discussion
The pathophysiology of VTE was elucidated by Vir-
chow more than 150 years ago and Virchow’s triad, 
comprising three elements - venous stasis, endothelial 
injury, and hypercoagulability - is still used to explain 
its development (8). In a review, Anderson and Spencer 
(8) verified that active cancer, together with advanced 
age, prolonged immobilization, type of operation, seri-
ous injury, previous VTE, and congestive heart failure, 
are “convincingly demonstrated” independent risk fac-
tors. Obesity, use of nicotine, chemotherapy, red cell 
transfusion, or coexisting medical conditions, could 
further increase the risk. 
The incidence of thromboembolic disease in general 
population is relatively low. Malignant diseases are con-
sidered a serious risk factor for the development of VTE 
(9). The incidence of VTE in head and neck cancer pa-
tients was reported as between 0.1% and 2%. However, 
it should be kept in mind that the true rates could have 
been underestimated because of the limitations of these 
studies. First, not all patients with VTE become symp-
tomatic. Second, the analysis relied, like all retrospec-
tive studies, on adequate record keeping. So far, rare 
had been reported in Chinese population on the topic of 
VTE, especially in oral and maxillofacial surgery.
In our study, several special characters had been re-
Fig. 1. PE diagnosed by CTA of pulmonary artery. (A) Pulmonary artery trunk was embolized. (B) Pulmonary arteriole was embolized. 
The arrows show the thrombus.
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vealed in oral and maxillofacial cancer patients and the 
perioperative treatment.
First, patients who suffered oral and maxillofacial can-
cer were usually elder. In our study of these 14 cases, 
13 patients were over 45 years old, 9 patients over 60 
and 6 patients over 70. The mean age was 62.07 years 
(Tables 1,4). And age was found to be a risk factor in 
patients with cancer associated VTE in several studies. 
On the other hand, occurrence of systemic disorder, for 
example hypertension, diabetes and cerebral infraction, 
in elder patients was higher than younger patient, which 
make the risk of VTE higher.
Second, oral and maxillofacial cancer patients usually 
need a radical resection, and the simultaneous recon-
struction is necessary for functional and aesthetical re-
quirement. Flap transplantation for the reconstruction 
of recipient defect always prolonged the surgery proce-
dure, otherwise, for the sake of adequate blood supply 
to the flap in head and neck region, and avoiding twist 
of vascular pedicel, patients with flap transplantation 
were required to lie on the back and immobilize at least 
for 3 days according to our department’s standard of 
care. In spite of lower extremity massage, immobiliza-
tion increased the risk of VTE. 
In our study, reconstruction was performed in 12 pa-
tients of these cases including 10 vascularized free flaps 
and 2 pedicel flaps (Table 5). ALTF and fibula flap were 
now very popular for reconstruction of soft tissue and 
osseous tissue defect respectively. In our study, three 
cases of DVT occurred on the ipsilateral of flap eleva-
tion, including ALTF, fibula flap and DCIA. 4 in 6 cases 
of PE got a reconstruction with ALTF. During flap ele-
vation, especially flaps involving lower extremity, GES 
and IHC were not convenient to use. Also, the transec-
tion and division make injury to lower extremity vessel, 
which was potential risk factor of DVT.
Third, DVC was applied universally during major sur-
gery in our department. Among the 8 patients of DVT, 
5 cases occurred on the ipsilateral of DVC and initial 
symptom was the pain and swelling at the puncture po-
sition (Table 3). The most favorite puncture position of 
DVC was right femoral vein because of increased po-
tential risk of thrombosis in left femoral vein, which 
was oppressed by iliac artery anatomically. Also, the 
puncture position verified depending on the donor site 
of flaps. Anyway, lower extremity DVC has a high cor-
relation with DVT according to our study. Although 
central venous access was recognized as a risk factor 
for VTE, rare had reported the correlation between 
DVT and lower extremity DVC as in our study.
Additionally, neck dissection was frequently necessary 
in head and neck cancer surgery because of high rate of 
lymph node metastasis. The division of jugular vein may 
result in endothelial injury, which was consistent with 
Virchow’s triad. Further more, the upper respiratory tract 
was usually involved in head and neck cancer surgery. To 
alleviate swelling and get airway unobstructed as soon as 
possible, high-dose glucocorticoid, which was elucidated 
as a risk factor of VTE, was applied. 
So far, more than 25 evidence-based guidelines on the 
prevention of VTE by the appropriate use of prophylaxis 
have been developed on the basis of results of clinical 
trials in different cohorts of at-risk patients since 1986. 
These include guidelines published by the American Col-
lege of Chest Physicians (ACCP) (10-12), the ninth edition 
of which was published in 2012 and those issued by the 
American Association of Orthopedic Surgeons (AAOS) 
(13) in 2012, which offer substantial insight into the risk 
of VTE as well as appropriate prophylaxis measures in 
orthopedic patients. Unfortunately there was no guide-
line for oral and maxillofacial surgery specifically.
Understanding guidelines and recommendations from 
other specialties will help us to make more appropri-
ate decision for our patients. The most widely used risk 
assessment tool was developed by Caprini (14). The 
Caprini risk assessment tool has been updated periodi-
cally since 30 years ago. According to this model, ap-
proximately 40 risk factors are listed, with weights of 1 
to 5 points each. The total risk factor score is then used 
to group patients into 1 of 4 categories (low, moderate, 
high, and highest risk), each with a recommended pro-
phylactic treatment. The Caprini risk assessment tool 
has been validated in retrospective studies for use in pa-
tients needing elective general surgery and modified for 
use in patients needing plastic surgery (15-18). We make 
a Caprini score for every case according to ACCP9 ret-
rospectively, found that every patient got a very high 
Caprini score (score≥9) (Table 3) and fell into high-risk 
group which should be dealt with aggressive thrombo-
prophylaxis. But in reality, only prophylactic alprostadil 
was used in 7 cases, no postoperative LMWH was ap-
plied prophylactically. The main concern was that rou-
tine prophylactic anticoagulation will increase the risk 
of postoperative hematoma, which can compromise 
flap viability or upper respiratory tract. Thus, currently 
few oral and maxillofacial surgeons routinely prescribe 
anticoagulation after resection and microvascular re-
construction. Meta-analysis has shown that pneumatic 
compression devices also decrease DVT in patients un-
dergoing surgical procedures by over 60%. But unfortu-
nately it was not available in our department. GES was 
also not widespread generalized because of apathetic 
awareness of VTE.
 
Conclusions 
In this study we aimed to identify potential risk fac-
tors for developing VTE for patients with head and neck 
cancer. We analyzed several characters of oral and max-
illofacial surgery and suggested pay attention to lower 
extremity DVC which had a high correlation with DVT 
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according to our data. And challenges to patient care in 
our department include lack of equipment like IHC, ap-
plication of GES and et al.
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